These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29220333)

  • 1. Feline Transdermal Formulation Considerations.
    Forsythe LE
    Int J Pharm Compd; 2017; 21(6):446-452. PubMed ID: 29220333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compounding Transdermal Medication for Feline Patients.
    Eichstadt LR
    Int J Pharm Compd; 2016; 20(4):271-274. PubMed ID: 28333671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To compound or not to compound: a veterinary transdermal discussion.
    Eichstadt LR; Davidson GS
    Int J Pharm Compd; 2014; 18(5):366-9. PubMed ID: 25577884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential and problems of developing transdermal patches for veterinary applications.
    Riviere JE; Papich MG
    Adv Drug Deliv Rev; 2001 Sep; 50(3):175-203. PubMed ID: 11500227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical and transdermal delivery of caffeine.
    Luo L; Lane ME
    Int J Pharm; 2015 Jul; 490(1-2):155-64. PubMed ID: 26004004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of feline hypertension with transdermal amlodipine: a pilot study.
    Helms SR
    J Am Anim Hosp Assoc; 2007; 43(3):149-56. PubMed ID: 17473021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex-vivo study of the percutaneous absorption of a tramadol formulation through feline inner pinna skin.
    Beuve MS; Espana B; Pin D; Prouillac C
    Res Vet Sci; 2022 Dec; 151():57-63. PubMed ID: 35868201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variations in percutaneous absorption of methimazole: an in vitro study on cat skin.
    Hill KE; Chambers JP; Jones BR; Bolwell CF; Aberdein D; Mills PC
    J Vet Pharmacol Ther; 2015 Dec; 38(6):616-8. PubMed ID: 25728360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation effects of topical emulsions on transdermal and dermal delivery.
    Otto A; du Plessis J; Wiechers JW
    Int J Cosmet Sci; 2009 Feb; 31(1):1-19. PubMed ID: 19134123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release veterinary parenteral products.
    Medlicott NJ; Waldron NA; Foster TP
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism.
    Hill KE; Gieseg MA; Kingsbury D; Lopez-Villalobos N; Bridges J; Chambers P
    J Vet Intern Med; 2011; 25(6):1357-65. PubMed ID: 22092628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azone analogues: classification, design, and transdermal penetration principles.
    Jampilek J; Brychtova K
    Med Res Rev; 2012 Sep; 32(5):907-47. PubMed ID: 22886628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Analgesic Drug Delivery and Nanobiotechnology.
    Stoicea N; Fiorda-Diaz J; Joseph N; Shabsigh M; Arias-Morales C; Gonzalez-Zacarias AA; Mavarez-Martinez A; Marjoribanks S; Bergese SD
    Drugs; 2017 Jul; 77(10):1069-1076. PubMed ID: 28470586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More economical use of cyclosporine through combination drug therapy.
    Daigle JC
    J Am Anim Hosp Assoc; 2002; 38(3):205-8. PubMed ID: 12022403
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
    Ham AS; Buckheit RW
    Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.